ACS Medicinal Chemistry Letters · 2013 · 14 citations · 6 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntiviral TherapyChemical Library DesignHit-to-lead OptimizationLinker ChemistryPotency OptimizationStructure-activity Relationship AnalysisAbsolute PotencyAntiviral Structure-activity RelationshipsHepatitis C GenotypesSonogashira CouplingStructure - Activity Relationship OptimizationStructure-activity Relationship Guided DesignThiazole ChemistryVirus Genotypes
The discovery of potent thienoimidazole-based HCV NS5A inhibitors is herein reported. A novel method to access the thienoimidazole [5,5]-bicyclic system is disclosed. This method gave access to a common key intermediate (6) that was engaged in Suzuki or Sonogashira reactions with coupling partners bearing different linkers. A detailed study of the structure-activity relationship (SAR) of the linkers revealed that aromatic linkers with linear topologies are required to achieve high potency for both 1a and 1b HCV genotypes. Compound 20, with a para-phenyl linker, was identified as a potential lead displaying potencies of 17 and 8 pM against genotype 1a and 1b replicons, respectively.
6
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 937 citations · Full text
Identification of Hepatitis C Virus NS5A Inhibitors
Julie A. Lemm, Donald R. O’Boyle, Mengping Liu et al. · Journal of Virology · 2009 · 194 citations · Full text